greeksoup/ stock research
Stock research / United States / XENE / Planned sales

Xenon Pharmaceuticals Inc. planned insider sales

In the last twelve months insiders at Xenon Pharmaceuticals Inc. filed 15 Form 144 notices of planned sales, 381,589 shares worth $22.0 million at the time of filing, from 7 sellers. The latest, filed 28 August 2026: Christopher Kenney (officer), 7,068 shares worth $437,721, planned for around 28 August 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
28 August 2026Christopher KenneyOfficer7,068$437,72128 August 20267,068 shares from 28 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted and Performance Stock UnitsForm 144
13 August 2026Steven GannonDirector10,000$640,55311 August 2026None on Form 4 yetRBC Wealth ManagementExercise of Options; Open Market PurchaseForm 144
5 June 2026Gillian CannonDirector1,190$63,0585 June 20261,190 shares from 5 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
5 June 2026Gary PatouDirector1,322$70,0535 June 20261,322 shares from 5 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
13 March 2026Andrea DifabioOfficer1,342$74,11213 March 20261,342 shares from 13 March 2026Morgan Stanley Wealth Management Canada Inc.Restricted share unit award vestingForm 144
13 March 2026Christopher John KenneyOfficer1,410$77,86713 March 20261,410 shares from 13 March 2026Morgan Stanley Wealth Management Canada Inc.Restricted share unit award vestingForm 144
13 March 2026Ian MortimerOfficer, Director7,308$403,58313 March 20267,308 shares from 13 March 2026Morgan Stanley Wealth Management Canada Inc.Restricted share unit award vestingForm 144
10 March 2026Andrea DifabioOfficer2,607$156,70210 March 20262,607 shares from 10 March 2026Morgan Stanley Wealth Management Canada Inc.Performance share unit award vestingForm 144
10 March 2026Christopher John KenneyOfficer2,771$166,55910 March 20262,771 shares from 10 March 2026Morgan Stanley Wealth Management Canada Inc.Performance share unit award vestingForm 144
10 March 2026Ian MortimerOfficer, Director11,269$677,35710 March 2026281,269 shares from 9 March 2026Morgan Stanley Wealth Management Canada Inc.Performance share unit award vestingForm 144
9 March 2026Ian MortimerOfficer, Director270,000$16.3 million9 March 2026No matching Form 4 saleCanaccord Genuity Corp.Exercise of OptionsForm 144
2 January 2026Ian MortimerOfficer, Director40,000$1.8 million2 January 202640,000 shares from 2 January 2026Canaccord Genuity Corp.Exercise of OptionsForm 144
8 December 2025Ian MortimerOfficer, Director10,830$495,2488 December 202510,830 shares from 8 December 2025Canaccord Genuity Corp.Exercise of OptionsForm 144
5 December 2025Ian MortimerOfficer, Director14,375$647,3605 December 202514,375 shares from 5 December 2025Canaccord Genuity Corp.Exercise of OptionsForm 144
1 December 2025Ian MortimerOfficer, Director97$4,36628 November 2025No matching Form 4 saleCanaccord Genuity Corp.Exercise of OptionsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?